Market Expansion Stratpharma is actively extending into topical dermatology beyond scar and wound healing, indicating a potential for cross-sell of dermatology-focused devices and wound care solutions to existing and new customers in clinics, hospitals, and aesthetic centers.

North America Growth With a dedicated North America Chief Commercial Officer appointed and a San Diego-based subsidiary, there is a clear focus on expanding sales and distribution in the US market, offering opportunities for regional partnerships, distributors, and direct-to-consumer or clinic channels.

Awarded Credibility A history of industry awards for wound care and postoperative products (Stratamed, Scar products) enhances credibility with key decision-makers, enabling faster engagement for new product introductions and hospital/clinic procurement pitches.

Dermatology Synergy Current portfolio strengths in dermatology, plastic surgery, burns, wounds, and scar management align with growing demand in cosmetic and reconstructive procedures, presenting cross-sell opportunities to dermatology practices, ambulatory surgery centers, and burn units.

Strategic Partnerships Recent leadership appointments and participation in major congresses (ONS Congress 2026) signal openness to strategic partnerships, collaborations, and channel partnerships that could accelerate product adoption and regional market penetration.